Prevalence of neuroleptic-induced restless legs syndrome in patients taking neuroleptic drugs

Abstract Dopamine deficiency or dopamine dysfunction has been implicated as one of the factors involved in the pathophysiology of restless legs syndrome (RLS). Our objective is to determine the prevalence of primary RLS in patients taking neuroleptic drugs. One hundred patients taking neuroleptic dr...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of the neurological sciences Vol. 314; no. 1; pp. 158 - 160
Main Authors:	Jagota, Priya, Asawavichienjinda, Thanin, Bhidayasiri, Roongroj
Format:	Journal Article
Language:	English
Published:	Amsterdam Elsevier B.V 15-03-2012 Elsevier
Subjects:	Adult Antidepressive Agents, Tricyclic - adverse effects Antipsychotic Agents - adverse effects Benzodiazepines - adverse effects Biological and medical sciences Cholinergic Antagonists - adverse effects Depressive Disorder - complications Depressive Disorder - drug therapy Dopamine Female Humans Male Medical sciences Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Neuroleptics Neurology Perphenazine - adverse effects Restless legs syndrome Restless Legs Syndrome - chemically induced Restless Legs Syndrome - epidemiology Serotonin Uptake Inhibitors - adverse effects Restless legs syndrome Neuroleptics Dopamine Human Sensitivity disorder Nervous system diseases Prevalence Neuroleptic Neurotransmitter Catecholamine Neurological disorder
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!